Kolmar Korea is to become the new owner of CJ HealthCare Corp., the pharma affiliate of CJ Group, in an acquisition deal valued at KRW1.31tn ($1.21bn), underscoring Kolmar's strong intent to expand and diversify its pharma business to grow into a top healthcare company in South Korea with international ambitions.
The sale of CJ HealthCare has been closely eyed since its largest shareholder CJ CheilJedang Corp. put the company up...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://insights.citeline.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

